Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stepwise Insulin Intensification with Detemir/Aspart vs Biphasic Aspart 30 in T2D
NCT01068652Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2010
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 4 trial of insulin detemir, insulin aspart, biphasic insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2010; status: completed.
02
Drugs
insulin detemirinsulin aspartbiphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01068652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01068652.